Trials / Unknown
UnknownNCT02605941
DNA Methylation Biomarkers for Cervical Cancer Screening
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 5,000 (estimated)
- Sponsor
- iStat Biomedical CO., Ltd. · Industry
- Sex
- Female
- Age
- 20 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this prospective study is to evaluate whether DNA methylation can be applied in cervical cancer screening.
Conditions
Timeline
- Start date
- 2014-02-01
- Primary completion
- 2015-12-01
- Completion
- 2016-08-01
- First posted
- 2015-11-17
- Last updated
- 2015-11-17
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT02605941. Inclusion in this directory is not an endorsement.